Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

JOHNSON & JOHNSON

(JNJ)
  Report
Real-time Estimate Cboe BZX  -  07:53:06 2023-03-22 am EDT
153.23 USD   -0.43%
03/20The Texas Two-Step Is Alive And Well
AQ
03/20Janssen Pharmaceutical - TREMFYA Real-World Data Analyses Show Greater Treatment Persistence than IL-17s in Both Bio-naive and Bio-experienced Patients Living with Moderate to Severe Plaque Psoriasis
AQ
03/15Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:

- pharmaceutical products (55.5%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;

- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;

- products for consumption by the general public (15.6%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.

At the end of 2021, Johnson & Johnson has 85 manufacturing facilities located in the United States (26), North America (9), Europe (25), Africa and Asia/Pacific (25).

Net sales break down geographically as follows: the United States (50.3%), North America (6.1%), Europe (25.2%), Asia/Pacific and Africa (18.4%).

Number of employees : 152 700 people.
Sales per Business
20212022Delta
Pharmaceutical52 080.0055.5%52 563.0055.4% +0.93%
Medical Devices27 060.0028.9%27 427.0028.9% +1.36%
Consumer14 635.0015.6%14 953.0015.7% +2.17%
USD in Million
Sales per region
20212022Delta
United States47 156.0050.3%48 580.0051.2% +3.02%
Europe23 594.0025.2%23 449.0024.7% -0.61%
Asia-Pacific, Africa17 275.0018.4%16 789.0017.7% -2.81%
Western Hemisphere Excluding United States5 750.006.1%6 125.006.5% +6.52%
USD in Million
Managers
Name Title Age Since
Joaquin Duato Chairman & Chief Executive Officer 59 2023
Joseph Wolk Chief Financial Officer & Executive Vice President 55 2018
Matthew Stuckley Senior Financial Analyst-Janssen Commercial Pharm - 2010
James Swanson Global Chief Information Officer & Executive VP 56 2019
Ahmet Tezel Global Head-Research & Development - 2022
Bernardo Tavares Chief Information Officer 54 -
Joanne Waldstreicher Chief Medical Officer 61 2022
Jessica Moore Vice President-Investor Relations - 2021
Marc Larkins Secretary - -
Jennifer Taubert Chairman-North America Pharmaceuticals - 2012
Members of the board
Name Title Age Since
Joaquin Duato Chairman & Chief Executive Officer 59 2023
Anne M. Mulcahy Lead Independent Director 69 2012
Ian Davis Independent Non-Executive Director 71 2010
A. Eugene Washington, Dr. Independent Director 71 2012
Mark B. McClellan, Dr. Independent Director 58 2013
D. Davis Independent Director 70 2014
Mary C. Beckerle, Dr. Independent Director 67 2015
Jennifer A. Doudna, Dr. Independent Director 58 2018
Marillyn Hewson Independent Director 69 2019
Hubert Joly Independent Director 62 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,626,088,548 2,600,900,730 71.7% 506,246,000 14.0% 71.7%
Shareholders
NameEquities%
The Vanguard Group, Inc. 236,271,620 9.07%
SSgA Funds Management, Inc. 142,084,378 5.46%
BlackRock Fund Advisors 57,943,605 2.22%
Geode Capital Management LLC 47,958,583 1.84%
Capital Research & Management Co. 32,520,000 1.25%
State Farm Investment Management Corp. 31,675,492 1.22%
T. Rowe Price Associates, Inc. (Investment Management) 29,277,774 1.12%
Wellington Management Co. LLP 26,861,119 1.03%
Norges Bank Investment Management 26,093,398 1.00%
Morgan Stanley Smith Barney LLC (Investment Management) 22,671,643 0.87%
Holdings
NameEquities%Valuation
IDORSIA LTD (IDIA) 9,581,882 5.11% 127,383,552 USD
MAUNA KEA TECHNOLOGIES (MKEA) 10,811,687 24.3% 6,913,858 USD
BIOCARTIS GROUP NV (BCART) 6,283,631 6.75% 4,191,496 USD
CRYO-CELL INTERNATIONAL, INC. (CCEL) 152,882 1.79% 584,009 USD
ALLIGATOR BIOSCIENCE AB (PUBL) (ATORX) 2,991,847 1.36% 414,281 USD
GRAIL, INC. 50,868,671 7.58% 509 USD
Markets and indexes
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Company contact information
Johnson & Johnson
1 Plaza Johnson et Johnson
NJ 08933 New Brunswick, New Jersey

Phone : +1 (732) 524 0400
Fax :
web site : http://www.jnj.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Johnson & Johnson
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
JOHNSON & JOHNSON-12.88%402 206
NOVO NORDISK A/S5.43%320 277
ELI LILLY AND COMPANY-9.50%300 873
ABBVIE INC.-2.99%275 418
MERCK & CO., INC.-4.88%268 710
PFIZER, INC.-20.65%230 348
ROCHE HOLDING AG-10.00%228 091
ASTRAZENECA PLC-2.80%205 199
NOVARTIS AG-8.19%188 787
BRISTOL-MYERS SQUIBB COMPANY-6.17%141 122
AMGEN INC.-11.30%125 335
SANOFI0.38%119 661
GILEAD SCIENCES, INC.-7.82%99 095
GSK PLC-0.67%70 016
DAIICHI SANKYO CO., LTD.5.62%65 464
BAYER AG18.32%58 966
TAKEDA PHARMACEUTICAL COMPANY LIMITED4.38%50 740
CHUGAI PHARMACEUTICAL CO., LTD-1.69%41 431
JIANGSU HENGRUI MEDICINE CO., LTD.7.97%37 468
ASTELLAS PHARMA INC.-8.67%24 871
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-4.02%24 835
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer